Raphael Pharmaceutical Inc. (RAPH) Net income 2020–2025
Raphael Pharmaceutical Inc. (RAPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.3MFY2025 · since FY2020: -$718,000 → -$1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.3M | +15.8% |
| FY2024 | -$1.5M | -13.0% |
| FY2023 | -$1.3M | +60.0% |
| FY2022 | -$3.4M | -106.6% |
| FY2021 | -$1.6M | -126.3% |
| FY2020 | -$718,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice